Fig. 3From: The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III study2 × 2 tables reporting urine culture data across treatment groups at 15th and 30th postoperative day (POD). *After excluding asymptomatic bacteriuriaBack to article page